This will probably contribute to the improvement of asthma control and the prevention of acute exacerbations. Triggers of acute exacerbations are generally hard to avoid. Therefore, preexisting ...
Benralizumab is a monoclonal antibody that targets specific white blood cells, called eosinophils, to reduce lung ...
Benralizumab can be used for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive pulmonary ...
Benralizumab can be used for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive pulmonary ...
Quintupling the ICS dose in children age 5 to 11 who lose asthma control may worsen outcomes in those with a higher socio-economic status.
Winter is here, and that can make it difficult for those with asthma to control their symptoms.The cold air that co ...
In recent weeks there has been a buzz around a new treatment breakthrough: benralizumab, which in a study published in the ...
However, primary care will need updated systems and capacity to identify and review exacerbations from all acute settings. A ...
It included 158 patients, randomly assigned treatment at the point of acute eosinophilic exacerbation of asthma or COPD. The study originally screened 287 patients for inclusion, but 129 were ...
When a person’s asthma is severe or isn’t managed well by typical protocols, they may be a good candidate for pulmonary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback